LON:SENS

Sensyne Health Share Forecast, Price & News

GBX 149.74

+0.74 (+0.50 %)

(As of 11/27/2020 11:15 AM ET)

Add

Compare

Today's Range

145.05

Now: GBX 149.74▼

150

50-Day Range

MA: GBX 115.09▼

150

52-Week Range

26.10

Now: GBX 149.74▼

153.08

Volume10,930 shs

Average Volume262,329 shs

Market Capitalization£192.52 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company's access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care's ‘Initial Code of Conduct for data-driven health and care technology'.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Sensyne Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 227.50, Sensyne Health has a forecasted upside of 51.9% from its current price of GBX 149.74.
Amount of Analyst Coverage
Sensyne Health has only been the subject of 1 research reports in the past 90 days.

3.9 Community Rank

Outperform Votes
Sensyne Health has received 71 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Sensyne Health has received 19 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Sensyne Health has received 78.89% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Sensyne Health and other stocks. Vote “Outperform” if you believe SENS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SENS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Sensyne Health does not currently pay a dividend.
Dividend Growth
Sensyne Health does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sensyne Health insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Sensyne Health is -8.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sensyne Health is -8.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Sensyne Health has a P/B Ratio of 4.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.48 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON

Industry Health Information Services

Sub-IndustryN/A

SectorComputer and Technology

Current SymbolLON:SENS

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.sensynehealth.com

Phone44 3300 581845

Employees70

Debt

Debt-to-Equity Ratio4.81

Current Ratio4.27

Quick Ratio4.18

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales£2.05 million

Price / Sales93.91

Cash FlowGBX 26.31 per share

Price / Cash Flow5.69

Book ValueGBX 34.10 per share

Price / Book4.39

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares128,572,000

Market Cap£192.52 million

Next Earnings DateN/A

OptionableOptionable

GBX 149.74

+0.74 (+0.50 %)

(As of 11/27/2020 11:15 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive SENS News and Ratings via Email

Sign-up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

Sensyne Health (LON:SENS) Frequently Asked Questions

How has Sensyne Health's stock price been impacted by COVID-19?

Sensyne Health's stock was trading at GBX 39 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SENS shares have increased by 283.9% and is now trading at GBX 149.74.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Sensyne Health?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensyne Health in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sensyne Health.

What stocks does MarketBeat like better than Sensyne Health?

Wall Street analysts have given Sensyne Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sensyne Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for SENS?

2 brokerages have issued twelve-month target prices for Sensyne Health's shares. Their forecasts range from GBX 195 to GBX 260. On average, they expect Sensyne Health's share price to reach GBX 227.50 in the next twelve months. This suggests a possible upside of 51.9% from the stock's current price.
View analysts' price targets for Sensyne Health.

Who are some of Sensyne Health's key competitors?

Some companies that are related to Sensyne Health include kneat.com, inc. (KSI.V) (KSI), Vitalhub Corp. (VHI.V) (VHI), Reliq Health Technologies Inc. (RHT.V) (RHT), Induction Healthcare Group PLC (INHC.L) (INHC), DIAGNOS Inc. (ADK.V) (ADK), IQ-AI Limited (IQAI.L) (IQAI), CardioComm Solutions, Inc. (EKG.V) (EKG), 1st Group Limited (1ST.AX) (1ST), Alcidion Group Limited (ALC.AX) (ALC), Cann American (CNNA), CannaOne Technologies (CNONF), CB2 Insights (CBIIF), CloudMD Software & Services (DOCRF), CloudMD Software & Services Inc. (DOC.V) (DOC) and Cogstate Limited (CGS.AX) (CGS).
View all competitors.

What other stocks do shareholders of Sensyne Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensyne Health investors own include Fresenius Medical Care AG & Co. KGaA (FME.F) (FME), Green Plains Partners (GPP), The Hershey (HSY), Gilead Sciences (GILD), Griffon (GFF), Emerald (EEX), DHX Media (DHXM), Ctrip.Com International (CTRP), Corus Entertainment (CJR) and Citizens Financial Group (CFG).

What is Sensyne Health's stock symbol?

Sensyne Health trades on the London Stock Exchange (LON) under the ticker symbol "SENS."

How do I buy shares of Sensyne Health?

Shares of SENS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Sensyne Health's stock price today?

One share of SENS stock can currently be purchased for approximately GBX 149.74.

How big of a company is Sensyne Health?

Sensyne Health has a market capitalization of £192.52 million and generates £2.05 million in revenue each year. Sensyne Health employs 70 workers across the globe.

What is Sensyne Health's official website?

The official website for Sensyne Health is www.sensynehealth.com.

How can I contact Sensyne Health?

The company can be reached via phone at 44 3300 581845.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings